SCHEMBL21590184

SCHEMBL21590184

CCC(c1ccccc1N)N1CCN(C)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MC4R P32245 17/20 0.50
ADRA2C P18825 1/20 0.45
CCR3 P51677 1/20 0.43
CHRM2 P08172 1/20 0.42
CHRM4 P08173 1/20 0.42
CHRM5 P08912 1/20 0.42
ADRA2A P08913 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
CYP2D6 P10635 1/20 0.42
CHRM1 P11229 1/20 0.42
CHRM3 P20309 1/20 0.42
DRD1 P21728 1/20 0.42
ADRA1D P25100 1/20 0.42
HTR2A P28223 1/20 0.42
HTR2C P28335 1/20 0.42
HRH1 P35367 1/20 0.42
OPRM1 P35372 1/20 0.42
DRD3 P35462 1/20 0.42
HTR2B P41595 1/20 0.42
SLC6A3 Q01959 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9923328 0.81 MC4R (0.72) MC4RCHRM2ADRA2ACHRM1DRD1
SCHEMBL14593276 0.76 MC4R (0.69) MC4RCCR3CHRM2CHRM4CHRM5
SCHEMBL11112394 0.73 MC4R (0.38) MC4RCCR3CHRM2CHRM4CHRM5
SCHEMBL1160038 0.71 DPP4 (0.68) MC4RCHRM2ADRA2ACHRM1DRD1
SCHEMBL19414179 0.69 MAPT (0.52) MC4R
SCHEMBL25375773 0.68 MC4R (0.62) MC4RCCR3CHRM2CHRM4CHRM5
SCHEMBL2843665 0.68 MC4R (0.62) MC4RCCR3CHRM2CHRM4CHRM5
SCHEMBL27921963 0.68 CYP1A2 (0.38) CYP2D6SLC6A3KCNH2
SCHEMBL12875000 0.68 MC4R (0.65) MC4RCCR3CHRM2CHRM4CHRM5
SCHEMBL2962625 0.67 OPRM1 (0.65) MC4RCCR3CHRM2CHRM4CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019238067-A1 PYRROLO [2, 3-B] PYRIDINES OR PYRROLO [2, 3-B] PYRAZINES AS HPK1 INHIBITOR AND THE USE THEREOF BEIGENE, LTD. (KY) 2019-12-19 WO disclosed